[The role of direct oral anticoagulants in the management of cancer-associated thrombosis in 2020]. [electronic resource]
Producer: 20200604Description: 574-585 p. digitalISSN:- 1769-6917
- ATP Binding Cassette Transporter, Subfamily B -- metabolism
- ATP Binding Cassette Transporter, Subfamily G, Member 2 -- metabolism
- Anticoagulants -- therapeutic use
- Antineoplastic Agents -- metabolism
- Cytochrome P-450 Enzyme System -- metabolism
- Dabigatran -- metabolism
- Drug Interactions
- Factor Xa Inhibitors -- adverse effects
- Hemorrhage -- chemically induced
- Heparin, Low-Molecular-Weight -- therapeutic use
- Humans
- Neoplasm Proteins -- metabolism
- Neoplasms -- blood
- Pyrazoles -- metabolism
- Pyridines -- metabolism
- Pyridones -- metabolism
- Recurrence
- Rivaroxaban -- metabolism
- Secondary Prevention
- Thiazoles -- metabolism
- Thrombosis -- drug therapy
- Venous Thromboembolism -- prevention & control
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.